Stock BIO.B BIO-RAD LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Market Closed - Nyse
Other stock markets
 21:15:00 10/05/2024 BST 		5-day change 1st Jan Change
279.9 USD 0.00% Intraday chart for Bio-Rad Laboratories, Inc. 0.00% -12.71%
05-08 UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating MT
05-08 RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bio-Rad: Q1 Earnings Snapshot
AQ
Bio-Rad Reports First-Quarter 2024 Financial Results
BU
Bio-Rad's Management to Participate in Fireside Chat during RBC Capital Markets Global Healthcare Conference
AQ
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
BU
Bio-Rad Announces Life Science Group Management Changes
AQ
Bio-Rad Announces Life Science Group Management Changes
BU
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
BU
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
AQ
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
AQ
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
BU
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
BU
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
BU
Bio-Rad: Q4 Earnings Snapshot
AQ
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
BU
Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
BU
Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 42nd Annual Healthcare Conference
AQ
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
BU
Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.
AQ
Bio-Rad: Q3 Earnings Snapshot
AQ
Bio-Rad Reports Third-Quarter 2023 Financial Results
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIO Stock
  4. BIO.B Stock
  5. News Bio-Rad Laboratories, Inc.
  6. Press Releases